3
项与 Adenovirus-transfected DCs+ CIK(Affiliated Hospital to Academy of Military Medical Sciences) 相关的临床试验 / Unknown status临床1/2期IIT Safety and Efficacy of DC Vaccine Combined With Cytokine-induced Killer Cells in Patients With Advanced Non-Small-Cell Lung Cancer With Bone Metastases: a Phase I/II Study
The purpose of this Phase I/II study is to evaluate the safety and efficacy of dendritic cells(DC) vaccine combined with cytokine-induced killer (CIK) cells in patients with Advanced Non-Small-Cell Lung Cancer with bone metastases. Experimental DC was transfected Ad5 vector coding mRNAs including suppressor of cytokine signaling (SOCS) 1, MUC1 and Survivin,are used for DC-based immunotherapy. Based on the results of our previously preclinical study with DC vaccine combined with CIK cells, the investigators plan to perform the clinical trial.
/ Unknown status临床1/2期IIT Safety and Therapeutic Efficacy of DC Vaccine Combined With Cytokine-induced Killer Cells in Patients With Renal Cell Carcinoma: a Phase I/II Study
The aim of this Phase I/II study is to evaluate the safety and efficacy of dendritic cells (DC) vaccine combined with cytokine-induced killer (CIK) cells in patients with renal cell carcinoma. Experimental recombinant adenovirus-transfected DC, which engineered to express MUC1 and Survivin are used for DC-based immunotherapy. Based on the results of our previously performed preclinical study with DC vaccine combined with CIK cells, the investigators plan to perform the clinical trial.
/ Unknown status临床1/2期IIT Safety and Therapeutic Efficacy of DCs Vaccine Combined With Cytokine-induced Killer Cells in Patients With AML: a Phase Ⅰ/Ⅱ Study
The aim of this Phase Ⅰ/Ⅱ study is to evaluate the safety and efficacy of dendritic cells (DCs) vaccine combined with cytokine-induced killer (CIK) cells in patients with AML. Experimental recombinant adenovirus-transfected DCs, which engineered to express MUC1 and Survivin are used for DCs-based immunotherapy. Based on the results of our previously performed preclinical study with DCs vaccine combined with CIK cells, the investigators plan to perform the clinical trial.
100 项与 Adenovirus-transfected DCs+ CIK(Affiliated Hospital to Academy of Military Medical Sciences) 相关的临床结果
100 项与 Adenovirus-transfected DCs+ CIK(Affiliated Hospital to Academy of Military Medical Sciences) 相关的转化医学
100 项与 Adenovirus-transfected DCs+ CIK(Affiliated Hospital to Academy of Military Medical Sciences) 相关的专利（医药）
100 项与 Adenovirus-transfected DCs+ CIK(Affiliated Hospital to Academy of Military Medical Sciences) 相关的药物交易
